| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.139 | 58.157 | 54.862 | 89.677 | 103.526 | 109.884 | 146.809 | 113.652 | 257.194 | 211.058 |
| Total Income - EUR | 32.172 | 58.167 | 58.258 | 97.575 | 103.527 | 109.946 | 146.810 | 113.811 | 258.319 | 216.633 |
| Total Expenses - EUR | 24.983 | 39.655 | 53.220 | 60.815 | 33.204 | 33.976 | 63.470 | 60.308 | 78.950 | 106.521 |
| Gross Profit/Loss - EUR | 7.189 | 18.512 | 5.039 | 36.760 | 70.324 | 75.970 | 83.340 | 53.503 | 179.369 | 110.112 |
| Net Profit/Loss - EUR | 6.225 | 17.349 | 4.218 | 35.485 | 69.289 | 74.959 | 82.266 | 52.536 | 176.919 | 104.536 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Acormed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.281 | 6.468 | 5.661 | 4.992 | 8.059 | 11.816 | 16.447 | 12.755 | 68.594 | 42.875 |
| Current Assets | 39.287 | 33.164 | 31.022 | 57.055 | 79.191 | 82.839 | 104.155 | 115.032 | 188.224 | 227.878 |
| Inventories | 1.727 | 1.116 | 1.546 | 5.649 | 7.492 | 4.438 | 1.842 | 5.134 | 1.230 | 0 |
| Receivables | 9.597 | 8.866 | 4.894 | 14.684 | 30.669 | 37.498 | 55.025 | 70.979 | 148.094 | 81.806 |
| Cash | 27.964 | 23.183 | 24.582 | 36.722 | 41.030 | 40.903 | 47.287 | 38.920 | 38.899 | 146.072 |
| Shareholders Funds | 29.056 | 17.608 | 21.527 | 35.735 | 69.533 | 75.199 | 97.778 | 102.367 | 213.471 | 104.769 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 21.676 | 30.718 | 23.663 | 26.646 | 18.043 | 19.777 | 23.137 | 25.420 | 43.347 | 165.984 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Acormed Srl